Genetically Modified T Cells for the Treatment of Malignant Disease

Publisher： Karger

E-ISSN： 1660-3818|40|6|388-402

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.40, Iss.6, 2013-11, pp. : 388-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of renin: new evidence from cultured cells and genetically modified mice

By Bader Michael   Ganten Detlev  

Journal of Molecular Medicine, Vol. 78, Iss. 3, 2000-05 ,pp. : 130-139

Springer Publishing Company

Access to resources Recommend Favorite

Intratunical Injection of Genetically Modified Adipose Tissue‐Derived Stem Cells with Human Interferon α‐2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 7, 2015-07 ,pp. : 1533-1544

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Interstitial Brachytherapy in the Treatment of Malignant Disease

By  

Oncology Research and Treatment, Vol. 24, Iss. 3, 2001-07 ,pp. : 222-228

Karger

Access to resources Recommend Favorite

Myoepithelial Cells in the Control of Mammary Development and Tumorigenesis: Data From Genetically Modified Mice

By Faraldo Marisa   Teulière Jérôme   Deugnier Marie-Ange   Hosseraye Ilaria   Thiery Jean   Glukhova Marina  

Journal of Mammary Gland Biology and Neoplasia, Vol. 10, Iss. 3, 2005-07 ,pp. : 211-219

Springer Publishing Company

Access to resources Recommend Favorite

On target: Genetically modified cells show promise in targeted immunotherapy for advanced blood cancers

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 929-930

John Wiley & Sons Inc

Access to resources Recommend Favorite